Abstract
Teprotumumab (TEPEZZA (R)), a monoclonal antibody that inhibits the insulin-like growth factor 1 receptor (IGF-1R), is the first disease-modifying the......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
